Survival benefit of adjuvant TACE for patients with hepatocellular carcinoma and child-pugh B7 or B8 after hepatectomy

Survival benefit of adjuvant TACE for patients with hepatocellular carcinoma and child-pugh B7 or B8 after hepatectomy

Abstract Background & aims The benefit of postoperative adjuvant transcatheter arterial chemoembolization (pTACE) for patients with hepatocellular carcinoma (HCC), especially those with Child-Pugh (CP) B, remains controversial. This study aimed to assess the survival benefit of pTACE for HCC pat...

Full description

Bibliographic Details
Main Authors: Zhen-Yu Gao, Li-Ming Jin, Zheng-Kang Fang, Fang-Qiang Wei, Wen-Feng Lu, Xiao-Kun Huang, Cheng-Fei Du, Kai-Di Wang, Jian Cheng, Guo-Liang Shen, Dong-Sheng Huang, Jun-Wei Liu, Cheng-Wu Zhang, Lei Liang
Format: Article
Language:English
Published: BMC 2024-10-01
Series:BMC Cancer
Subjects:
Hepatocellular carcinoma
TACE
Child-pugh B
Hepatectomy
Survival
Online Access:https://doi.org/10.1186/s12885-024-13028-5

Internet

https://doi.org/10.1186/s12885-024-13028-5

Similar Items